[1] MUELLER N M, HYAMS T, KING-MARSHALL E C, et al. Colorectal cancer knowledge and perceptions among individuals below the age of 50[J]. Psychooncology, 2022, 31(3):436-441. [2] TSILIMIGRAS D I, SAHARA K, HYER J M, et al. Trends and outcomes of simultaneous versus staged resection of synchronous colorectal cancer and colorectal liver metastases[J]. Surgery, 2021, 170(1):160-166. [3] MA T, KONG M. Interleukin-18 and -10 may be associated with lymph node metastasis in breast cancer[J]. Oncol Lett, 2021, 21(4):253. [4] SU P, LAI W, LIU L, et al. Mesenchymal and phosphatase of regenerating liver-3 status in circulating tumor cells may serve as a crucial prognostic marker for assessing relapse or metastasis in postoperative patients with colorectal cancer[J]. Clin Transl Gastroenterol, 2020, 11(12):e00265. [5] LV Y, SUN D, HAN Q, et al. microRNA-425 promoted the proliferation and migration of colorectal cancer cells by targeting KLF3 through the PI3K/AKT pathway[J]. Minerva Med, 2021, 112(4):537-538. [6] QIAO T Y, YUAN Z M, MA T Y, et al. Claudin14 promotes colorectal cancer progression via the PI3K/AKT/mTOR pathway[J]. Neoplasma, 2021, 68(5):947-954. [7] 马西,杜鹏程,宁登,等. IL-13、COX2和PI3 K/Akt信号通路与结肠癌侵袭转移的关系[J]. 广东医学, 2020, 41(16):1637-1641. [8] 国家卫生计生委医政医管局, 中华医学会肿瘤学分会. 中国结直肠癌诊疗规范(2017年版)[J]. 中华胃肠外科杂志, 2018, 21(1):92-106. [9] 中华医学会外科学分会胃肠外科学组, 中华医学会外科学分会结直肠外科学组, 中国抗癌协会大肠癌专业委员会, 等. 中国结直肠癌肝转移诊断和综合治疗指南(2018版)[J]. 中华消化外科杂志, 2018, 17(6):527-539. [10] 田传鑫, 赵磊. 结直肠癌及结直肠癌肝转移流行病学特点[J]. 中华肿瘤防治杂志, 2021, 28(13):1033-1038. [11] 李亚林, 王巍, 孟庆松, 等. 莫迪司增强MRI联合血清CEA、CA19-9对结直肠癌肝转移的诊断价值[J]. 武汉大学学报(医学版), 2022, 43(3):412-416. [12] QADER G, AALI M, SMAIL S W, et al. Cardiac, hepatic and renal dysfunction and IL-18 polymorphism in breast, colorectal, and prostate cancer patients[J]. Asian Pac J Cancer Prev, 2021, 22(1):131-137. [13] QUATRINI L, VACCA P, TUMINO N, et al. Glucocorticoids and the cytokines IL-12, IL-15, and IL-18 present in the tumor microenvironment induce PD-1 expression on human natural killer cells[J]. J Allergy Clin Immunol, 2021, 147(1):349-360. [14] KANG J S, BAE S Y, KIM H R, et al. Interleukin-18 increases metastasis and immune escape of stomach cancer via the downregulation of CD70 and maintenance of CD44[J]. Carcinogenesis, 2009, 30(12):1987-1996. [15] SMITH C N, BLACKBURN J S. PRL-3 promotes a positive feedback loop between STAT1/2-induced gene expression and glycolysis in multiple myeloma[J]. FEBS J, 2021, 288(23):6674-6676. [16] LEIPHRAKPAM P D, LAZENBY A J, SMITH L M, et al. Correlation of PRL3 expression with colorectal cancer progression[J]. J Surg Oncol, 2021, 123(1):42-51. [17] KOLODZIEJ P, NICOS M, KRAWCZYK P A, et al. The correlation of mutations and expressions of genes within the PI3K/Akt/mTOR Pathway in breast cancer-a preliminary study[J]. Int J Mol Sci, 2021, 22(4):2061. [18] 冯跃, 张永涛, 夏利锋, 等. PI3K/Akt/mTOR信号通路相关蛋白在结直肠癌中的表达及与临床病理特征和预后的关系[J]. 中国现代医学杂志, 2020, 30(24):18-23. [19] 刘立, 盖金娜, 尹作文, 等. IL-18通过调控PI3K/AKT与NF-κb信号通路激活肿瘤免疫抑制结肠癌的机制[J]. 实用医学杂志, 2020, 36(5):575-580. [20] XIONG J, LI Z, ZHANG Y, et al. PRL-3 promotes the peritoneal metastasis of gastric cancer through the PI3K/Akt signaling pathway by regulating PTEN[J]. Oncol Rep, 2016, 36(4):1819-1828. |